Authors
Latest:
How Biopharma Can Accelerate Innovation and Sustain GrowthThere are clear pathways that biopharma companies can take to sustain growth and remain competitive.
Latest:
Fortifying Defenses Pre-Patent CliffIntegrating artificial intelligence and advanced analytics throughout operations offers pharma companies a pathway to offset impending drug patent expirations.
Latest:
Embedded and agile–The next phase of the DCT evolutionEllenor discusses key points from the recent SCOPE presentation.
Latest:
A Clear-Headed Approach to Migraine: Vlad Coric, BiohavenBiohaven CEO Vlad Coric talks to Pharm Exec about NURTEC ODT’s swift and seismic impact on the migraine market.
Latest:
Under PressurePromotional spending is down as companies rationalize and optimize budgets. But in contrast to big changes on the sales side, marketers are still trying to make the old model work
Latest:
Taking It Personally: Building Relationships OnlineTo increase impact and effectiveness, personalized Web sites should be constructed in different ways to interact with multiple audiences.
Latest:
Bringing in the GreenPharma can stand to win hearts, minds, and tax credits by launching an eco bandwagon
Latest:
Comparative Effectiveness Research: Coming Soon?Only time will reveal CER's true definition, and determine the full effects of a CER-based system
Latest:
My DM told me there'd be days like these…Everyone has bad days, but do you know how to make the best of them?
Latest:
Time to Step UpThe economy is turning around; leaders need to position their companies now for the market bounce.
Latest:
Helping Patients Lead the Way in the New NHSNHS England is currently undergoing profound changes to introduce a new culture where clinicians and patients are the new stars, where competition is mandatory, where everything rests on patient outcomes and where collaboration and innovation are being encouraged at the highest levels of command.
Latest:
Lack of Multichannel Confidence: A Step on the Road to Digital MaturityI’ve been lucky enough to get a sneak preview of Across Health’s 2014 Multichannel Barometer report.
Latest:
Special Report: Platform Drugs—Opportunities in the Market...How to stretch that portfolio to make ends meet
Latest:
Coping With KubinThe debate over gene sequence patents is leaving investors lost and confused. These strategies will help them find their way
Latest:
Harbingers of ChangeThe industry is a-changing. Here are eight seminal events that describe how.
Latest:
Bridging Industry's Charisma ChasmPharma’s image is still suffering despite a rise in medical innovation. Dan Bobear offers five patient-centered strategies that could help in finally mending the gap.
Latest:
Valuing DiversityVeteran salesperson Reggie Smith of Genentech makes the case for sales force diversity
Latest:
The Changing World of Med EdFor years, medical education activities have been a sure way for pharma marketers to deliver key messages to the medical community about scientific discoveries, new treatments, and products fostering medical advancement. The most effective activities advance physicians' knowledge and motivate them to act.
Latest:
Generics Battle Heats UpThe competition for generics' 180-day marketing exclusivity is fierce, and Dr. Reddy's Laboratories filed the first court case calling into question FDA's methods for determining exclusivity on a patent-by-patent basis.
Latest:
Same Rod, Bigger FishAs pharmaceutical companies look to emerging markets to offset slowed growth at home, success will depend on efficient re-use of regulatory content to target new high-growth markets.
